By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Ontario Genomics Institute has invested C$100,000 (US$101,000) in Toronto-based molecular diagnostics developer Rna Diagnostics to support further development of the company's lead test for chemotherapy management.

OGI provided the funding to Rna Diagnostics, which has its research lab in Sudbury, Ontario and uses technology developed at Sudbury's Laurentian University, through its Pre-Commercialization Business Development Fund.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.